Display options
Cite
Li R, Ong SL, Tran LM, et al. Author Correction: Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. Sci Rep. 2020;10(1):4386doi: 10.1038/s41598-020-61341-3.
Li, R., Ong, S. L., Tran, L. M., Jing, Z., Liu, B., Park, S. J., Huang, Z. L., Walser, T. C., Heinrich, E. L., Lee, G., Salehi-Rad, R., Crosson, W. P., Pagano, P. C., Paul, M. K., Xu, S., Herschman, H., Krysan, K., & Dubinett, S. (2020). Author Correction: Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. Scientific reports, 10(1), 4386. https://doi.org/10.1038/s41598-020-61341-3
Li, Rui, et al. "Author Correction: Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer." Scientific reports vol. 10,1 (2020): 4386. doi: https://doi.org/10.1038/s41598-020-61341-3
Li R, Ong SL, Tran LM, Jing Z, Liu B, Park SJ, Huang ZL, Walser TC, Heinrich EL, Lee G, Salehi-Rad R, Crosson WP, Pagano PC, Paul MK, Xu S, Herschman H, Krysan K, Dubinett S. Author Correction: Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. Sci Rep. 2020 Mar 04;10(1):4386. doi: 10.1038/s41598-020-61341-3. PMID: 32127587; PMCID: PMC7054550.
Copy Download .nbib Format: NLM
Share it on

Sci Rep. 2020 Mar 04;10(1):4386. doi: 10.1038/s41598-020-61341-3.

Author Correction: Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer.

Scientific reports

Rui Li, Stephanie L Ong, Linh M Tran, Zhe Jing, Bin Liu, Stacy J Park, Zi Ling Huang, Tonya C Walser, Eileen L Heinrich, Gina Lee, Ramin Salehi-Rad, William P Crosson, Paul C Pagano, Manash K Paul, Shili Xu, Harvey Herschman, Kostyantyn Krysan, Steven Dubinett

Affiliations

  1. Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, 90025, California, USA.
  2. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, 90025, California, USA.
  3. Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, 90025, California, USA.
  4. Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, 90025, California, USA.
  5. VA Greater Los Angeles Health Care System, Los Angeles, California, 90025, USA.
  6. Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, 90025, California, USA. [email protected].
  7. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, 90025, California, USA. [email protected].
  8. Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, 90025, California, USA. [email protected].
  9. Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, 90025, California, USA. [email protected].
  10. VA Greater Los Angeles Health Care System, Los Angeles, California, 90025, USA. [email protected].

PMID: 32127587 PMCID: PMC7054550 DOI: 10.1038/s41598-020-61341-3

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication Types